Number of shareholders of Veeva Systems Inc Class A – LSX:A1W5SA
This article provides financial information for Veeva Systems Inc Class A (LSX:A1W5SA) on TradingView, specifically focusing on the number of shareholders. It notes that the market is closed and displays a placeholder for period value changes related to shareholder data.
Veeva Systems director Priscilla Hung sells $116,729 in stock
Veeva Systems director Priscilla Hung sold 750 shares of Class A Common Stock for $116,729 on April 30, 2026, under a Rule 10b5-1 trading plan. The company recently joined the S&P 500, announced its General Counsel's retirement, and received a "Buy" rating from Stifel due to its AI potential. Veeva Systems is also noted for holding more cash than debt, suggesting it may be undervalued.
Veeva Systems director Priscilla Hung sells $116,729 in stock
Veeva Systems director Priscilla Hung sold 750 shares of Class A Common Stock for a total of $116,729 on April 30, 2026. The sale occurred at $155.64 per share and was conducted under a Rule 10b5-1 trading plan. Despite the sale, Hung still owns 3,253 shares, and the stock price has since increased by nearly 9%.
Veeva Systems director Priscilla Hung sells $116,729 in stock
Veeva Systems director Priscilla Hung sold 750 shares of Class A Common Stock for $116,729 on April 30, 2026, as part of a Rule 10b5-1 trading plan. The company, recently added to the S&P 500, is considered undervalued and has a "GREAT" financial health rating, with Stifel reiterating a Buy rating with a $245.00 price target. This sale comes amidst other significant developments for Veeva, including a change in its S&P 500 status and upcoming executive retirement.
Veeva Systems (NYSE: VEEV) director sells 750-share lot under plan
Veeva Systems director Priscilla Hung reported an open-market sale of 750 shares of Class A Common Stock on April 30, 2026, at $155.64 per share. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 12, 2026. Following the sale, Hung directly holds 3,253 shares.
Veeva Systems Inc (XTER:VEE) - Valuation Measures & Financial Statistics
This article provides a detailed overview of Veeva Systems Inc (XTER:VEE)'s valuation measures and financial statistics, pulling data from GuruFocus. It lists numerous fundamental, valuation ratio, profitability, price, dividend, income statement, balance sheet, cash flow statement, and technical indicator metrics available for the company. The page also includes essential stock information like real-time price, market cap, P/E, and P/B ratios.
Why We Think Veeva Systems Is Still Built to Last After the Stock’s Selloff
Morningstar analysts continue to rate Veeva Systems (VEEV) with a wide economic moat, despite a recent stock selloff fueled by AI fears. They believe the company's R&D solutions business, which makes up 55% of revenue, will continue rapid growth due to high switching costs in a highly regulated life sciences industry. The selloff is attributed to broader market concerns about AI's impact on software companies rather than a change in Veeva's fundamentals, and the stock is considered significantly undervalued.
Hung Priscilla, Veeva Systems director, sells $115k in shares
Veeva Systems director, Hung Priscilla, sold 750 shares of Class A Common Stock for $153.5 each, totaling $115,125, through a Rule 10b5-1 trading plan. This sale occurred while VEEV stock was near its 52-week low. The company recently acquired Ostro for $100 million to enhance its AI strategy, with analysts maintaining various ratings and price targets.
Hung Priscilla, Veeva Systems director, sells $115k in shares
Veeva Systems director Hung Priscilla sold 750 shares of Class A Common Stock for $115,125, executed under a Rule 10b5-1 trading plan. This sale occurred while VEEV stock is near its 52-week low. In other news, Veeva Systems acquired Ostro for approximately $100 million, aligning with its AI integration strategy, and has received reiterations of Outperform and Buy ratings from analysts like William Blair and Stifel, despite a price target adjustment from Needham due to valuation concerns.
Director Priscilla Hung sells 750 Veeva (NYSE: VEEV) shares under 10b5-1 plan
Veeva Systems director Priscilla Hung sold 750 shares of Class A Common Stock at $153.50 per share on April 10, 2026, under a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Hung directly owns 4,003 shares of Veeva Systems. The sale was valued at $115,125 and was disclosed in a Form 4 filing.
Hung Priscilla, Veeva Systems director, sells $115k in shares
Veeva Systems Director Hung Priscilla sold 750 shares of Class A Common Stock for $115,125 on April 10, 2026, under a Rule 10b5-1 trading plan. The sale occurred while VEEV stock was near its 52-week low, though InvestingPro analysis suggests the stock is undervalued. This news comes amid Veeva's recent acquisition of Ostro and reiterated positive ratings from analysts like William Blair and Stifel.
Veeva Systems (NYSE: VEEV) CFO receives new Restricted Stock Unit grants
Veeva Systems CFO Brian Van Wagener received two grants of Restricted Stock Units (RSUs) on April 7, 2026, totaling 6,541 and 11,628 shares of Class A common stock, respectively. These grants are part of his compensation and are subject to vesting conditions based on continued service. One award vests quarterly over approximately one year starting July 1, 2026, while the other vests 100% on April 1, 2030, with no share sales involved in these transactions.
CAO Vipin Kondath awarded RSUs at Veeva Systems (NYSE: VEEV)
Veeva Systems' Chief Accounting Officer, Vipin Kondath, received two grants of Restricted Stock Units (RSUs) as part of his compensation. These awards, totaling 669 and 5,884 RSUs respectively, will vest on different schedules contingent on his continued service to the company. The grants are exempt from Section 16(b) of the Securities Exchange Act of 1934 and are being issued under the company's Amended & Restated 2013 Equity Incentive Plan.
Veeva Systems (VEEV) SVP Jonathan Faddis granted 6,541 RSUs under equity plan
Jonathan Faddis, SVP, General Counsel and Secretary of Veeva Systems (VEEV), was granted 6,541 Restricted Stock Units (RSUs) under the company's Amended & Restated 2013 Equity Incentive Plan. These RSUs convert into Class A common shares and will vest over one year, with a quarter vesting on July 1, 2026, and the remainder in equal quarterly installments, contingent on his continued employment. Following this grant, Faddis directly holds 6,541 shares/units related to this award.
Veeva Systems (NYSE: VEEV) president granted RSUs vesting through 2030
Veeva Systems President & Chief Customer Officer Thomas D. Schwenger was granted two Restricted Stock Unit (RSU) awards, totaling 11,628 and 14,535 shares of Class A common stock, respectively. These awards constitute equity compensation subject to continued service. The first RSU grant vests over one year starting July 1, 2026, while the second award vests entirely on April 1, 2030, with both exempt from Section 16(b) short-swing profit rules.
Veeva Systems stock hits 52-week low at $168.10
Veeva Systems (VEEV) stock recently hit a new 52-week low of $168.10, marking a 22.28% decrease over the past year, despite InvestingPro data suggesting it may be undervalued. The company, with a market capitalization of $27.65 billion, reported a 16.34% revenue growth and has seen 15 analysts revise earnings upwards. This decline comes amidst recent strategic moves including the acquisition of Ostro and varying analyst ratings, with some reiterating "Buy" and others lowering price targets due to valuation concerns.
Veeva Systems (NYSE: VEEV) SVP vests RSUs and covers taxes in shares
Veeva Systems SVP and General Counsel, Jonathan Faddis, recently derived 8,726 Class A shares from the vesting of restricted stock units (RSUs). To cover tax obligations, 3,810 shares were withheld by the company at a price of $172.74 per share, which was not a market sale. Following these transactions, Faddis directly holds 8,525 shares of Veeva Systems Class A Common Stock.
Veeva Systems (NYSE: VEEV) CFO nets shares after RSU vesting and tax withholding
Veeva Systems Inc.'s CFO, Brian Van Wagener, exercised 872 Restricted Stock Units (RSUs) on April 1, 2026, converting them into shares of Class A Common Stock. To cover tax obligations, 370 shares were withheld by Veeva at $172.74 per share, which was a tax payment mechanism and not an open-market sale. Following these transactions, the CFO directly holds 8,383 shares of Class A Common Stock.
Veeva Systems (NYSE: VEEV) president converts RSUs, retains 31,238 shares
Eleni Nitsa Zuppas, President & Chief of Staff at Veeva Systems (NYSE: VEEV), recently converted 8,998 restricted stock units (RSUs) into Class A Common Stock. A total of 4,002 shares were withheld to cover tax obligations at a price of $172.74 per share, which was not a market transaction. Following these transactions, Ms. Zuppas directly holds 31,238 shares of Class A Common Stock.
Veeva Systems (VEEV) CAO converts RSUs, withholds 957 shares for taxes
Veeva Systems' Chief Accounting Officer, Vipin Kondath, engaged in routine equity compensation activity where 2,603 restricted stock units (RSUs) were converted into Class A Common Stock. To satisfy tax obligations, 957 shares were withheld at a price of $172.74 per share. After these transactions, Kondath directly held 2,676 shares of Class A Common Stock, with the activities noted as exempt from Section 16(b) of the Securities Exchange Act of 1934.
Veeva Systems (VEEV) exec nets shares after 2,043 RSUs vest
Veeva Systems' President & Chief Customer Officer, Thomas D. Schwenger, settled 2,043 Restricted Stock Units (RSUs) into Class A Common shares on April 1, 2026. To cover tax obligations, 588 shares were withheld by Veeva at $172.74 per share. After these transactions, Schwenger directly holds 23,659 shares of Veeva Systems Class A Common Stock.
Veeva Systems Inc (XTER:VEE) Stock Price, Trades & News
This GuruFocus page provides a comprehensive overview of Veeva Systems Inc (XTER:VEE) stock, including real-time price, key financial metrics, valuation, growth ranks, and news. It also details the company's business description, upcoming earnings dates, and acquisition history, marking it as a leading cloud software provider for the life sciences industry.
Customer Wins, New Products, and AI Investment Support Veeva's Long-Term Growth Momentum
Veeva, a leading cloud-based software provider for the life sciences industry, is supported by customer wins, new product offerings, and investments in AI, ensuring its long-term growth. The company's strategy of focusing on a single industry allows it to tailor solutions precisely to customer needs, enhancing its market penetration and product portfolio. This vertical focus positions Veeva as an attractive offering in its specialized market.
Assessing Veeva Systems (VEEV) Valuation After AOP Health Expands Onto Its Unified Cloud Platforms
Veeva Systems (VEEV) recently saw AOP Health expand its operations onto its cloud platforms, showcasing the deep integration of Veeva's software. Despite this positive news, Veeva's stock has seen a significant decline over the past year, though it shows a slight recovery in the last week. The article discusses Veeva's valuation, noting it's considered undervalued by a key narrative due to potential market expansion and revenue growth, but its P/E ratio suggests the market already factors in optimism.
Here's How Much You Would Have Made Owning Veeva Systems Stock In The Last 10 Years
Veeva Systems (NYSE: VEEV) has significantly outperformed the market over the last decade, with an annualized return of 22.01%. An initial investment of $1000 in VEEV stock ten years ago would now be worth $7,353.17, highlighting the power of compounded returns. The article, generated by Benzinga's automated content engine, emphasizes the substantial growth potential of such investments over time.
VEEV SEC Filings - Veeva Sys Inc 10-K, 10-Q, 8-K Forms
This page provides access to Veeva Systems Inc. (VEEV) SEC filings, including annual reports (10-K), quarterly reports (10-Q), and material event disclosures (8-K). It details recent insider trading activities and the company's strong Q3 financial performance with increased revenue and EPS driven by subscription and professional services. The platform offers AI-powered summaries to help investors understand the significance of each document.
Veeva Systems Buys Ostro As AI Deal Undervalues Share Price
Veeva Systems has acquired Ostro, an AI-powered life sciences brand engagement platform, to enhance its commercial offerings for pharmaceutical and biotech customers. Despite the strategic acquisition leveraging AI for compliant communication with patients and doctors, Veeva's share price is currently undervalued, trading significantly below analyst targets and estimated fair value. Investors will be closely monitoring the integration of Ostro and customer adoption of the new AI tools to assess the deal's impact on Veeva's performance and market valuation.
Veeva Systems (NYSE:VEEV) Emerges as a Strong Growth Stock with a Promising Technical Setup
Veeva Systems (NYSE:VEEV) is highlighted as a compelling investment opportunity, combining strong fundamental growth with a promising technical setup. The company boasts outstanding earnings, a robust financial condition with no debt, and consistent double-digit growth. Technically, VEEV shows signs of basing and potential turnaround after a period of sideways movement, suggesting a favorable entry point for growth-focused investors.
Veeva Systems (NYSE: VEEV) exec pre-planned sale of 1,000 shares
Veeva Systems President & Chief Customer Officer, Thomas D. Schwenger, sold 1,000 shares of Class A common stock at $200.00 per share on March 5, 2026. This pre-planned transaction was executed under a Rule 10b5-1 trading plan adopted on October 14, 2025. Following the sale, Schwenger directly owns 22,204 shares of Veeva Systems.
AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
AOP Health, an international biopharma company, has standardized its R&D, quality, commercial, and data operations on Veeva Industry Cloud for Life Sciences. This move aims to accelerate innovation within the company, leveraging the Veeva Vault Platform. The announcement highlights Veeva Systems' continued growth and strong market position.
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV)
Three analysts recently issued bullish ratings on healthcare companies Veeva Systems (VEEV), BillionToOne, Inc. Class A (BLLN), and Solventum Corporation (SOLV). Wells Fargo assigned a Buy rating to Veeva Systems with a $317 price target, William Blair maintained a Buy rating on BillionToOne, Inc. Class A, and Morgan Stanley upheld a Buy rating for Solventum Corporation with a $103 price target. Based on analyst consensus, all three stocks show significant upside potential from their current levels.
Why Is Veeva Systems Stock Falling Today?
Veeva Systems Inc. (NYSE: VEEV) shares are down today following the announcement of its plan to acquire Ostro, a digital health platform. This acquisition, valued at approximately $100 million, aims to expand Veeva's artificial intelligence tools for pharmaceutical brands to interact with patients and healthcare professionals, reflecting a growing demand for compliant AI communication in healthcare. The deal introduces an AI-powered engagement platform that provides users with verified health information instantly, leveraging conversational AI and semantic search while adhering to compliance safeguards.
AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
AOP Health, a biopharma company specializing in rare diseases and critical care, is standardizing its operations on Veeva Industry Cloud for Life Sciences. This move aims to connect its R&D, quality, commercial, and data functions on the Veeva Vault Platform to streamline operations, eliminate silos, and accelerate the delivery of critical medicines. The adoption of Veeva's platform is expected to drive faster global growth and improve patient outcomes by enhancing efficiency and collaboration across various teams.
Veeva Earnings: Strong Close to Fiscal 2026 and Impressive 2027 Guidance Tame Investor Fears
Veeva Systems (VEEV) reported strong fourth-quarter fiscal 2026 results with a 16% year-over-year revenue growth and a 20% increase in adjusted EPS. The company also provided optimistic initial revenue and EPS guidance for fiscal 2027, surpassing FactSet consensus estimates. This positive news led to a 7% jump in shares during early trading.
RSU conversion gives Veeva Systems (NYSE: VEEV) director 253 shares
Veeva Systems director Paul J. Sekhri received 253 shares of Veeva Class A common stock through the vesting and exercise of Restricted Stock Units (RSUs) on March 1, 2026. These RSUs were part of a larger grant from June 2025 under the company's equity incentive plan, and the transaction is exempt from Section 16(b). Following this conversion, Sekhri directly owns 14,938 shares of Class A common stock.
Veeva Earnings Beat Resets Expectations For Vault CRM And AI Transition
Veeva Systems (NYSE:VEEV) announced a strong Q4 earnings beat, generating $835.95 million in revenue and $244.2 million in net income, and issued robust fiscal 2027 revenue guidance of $3.59b-$3.60b. The company also unveiled a new $2 billion share repurchase program and is accelerating customer migration to its Vault CRM platform while expanding AI-driven automation. This combination of strong financial performance, capital return, and strategic product transitions sets new expectations for Veeva's future growth and market positioning.
How Is The Market Feeling About Veeva Systems Inc?
Veeva Systems Inc.'s (NYSE: VEEV) short interest has increased by 26.43% since its last report, indicating a growing bearish sentiment from investors. Currently, 6.33 million shares are sold short, representing 4.21% of its available shares, and it would take traders 2.13 days to cover these positions. Despite the rise, Veeva Systems' short interest is lower than its peer group average of 8.39%.
Why Veeva Systems Shares Are Rocketing After Q4 Results
Veeva Systems (NYSE: VEEV) shares surged after the company reported strong fourth-quarter financial results that exceeded analyst expectations, with revenue up 16% year-over-year to $836 million and EPS of $2.06. The cloud-based software firm also provided optimistic guidance for the first quarter and the next fiscal year, projecting revenue significantly above Street estimates. Leadership attributed this success to strategic initiatives like Veeva AI and strong performance across its commercial, development, and quality cloud segments, aiming for a $6 billion revenue run rate by 2030.
Is Veeva (VEEV) Turning Vault CRM Adoption Into a Deeper Life Sciences Platform Advantage?
Veeva Systems (VEEV) has seen rapid adoption of its Vault CRM platform, with over 125 customers, including top biopharma companies, now live. This shift, coupled with integrated AI capabilities, strengthens Veeva's position as a core commercial platform in life sciences, as it transitions customers from its legacy CRM. While the company forecasts significant revenue and earnings growth, competitive pressure and customer pricing concerns present ongoing risks to its investment narrative.
Veeva Systems (VEEV) director adds shares through RSU conversion and family trust holdings
Veeva Systems (VEEV) director Timothy S. Cabral reported acquiring 262 Class A shares on March 1, 2026, through the vesting of Restricted Stock Units (RSUs) at $0.00 per share. After this transaction, he directly holds 787 Class A shares. Additionally, the Cabral Family Trust, where he is a trustee and beneficiary, indirectly holds 5,500 Class A shares.
Veeva Systems (NYSE: VEEV) director adds shares through 262-unit RSU conversion
Veeva Systems director Priscilla Hung increased her direct ownership by 262 shares of Class A Common Stock through the vesting and conversion of Restricted Stock Units (RSUs) on March 1, 2026. These RSUs were part of a larger grant from June 2025, vesting over time subject to her continued board service. Following this transaction, Hung directly owns 4,753 shares.
Veeva Systems (VEEV) director converts 262 RSUs into Class A shares
Veeva Systems director Mary Lynne Hedley reported an equity award transaction where 262 Restricted Stock Units were converted into Class A common stock on March 1, 2026, at a price of $0.00 per share. Following this conversion, her direct holdings of Class A common stock total 6,890 shares. The RSUs are part of a 1,049-unit grant from June 2025, vesting quarterly subject to her continued service on the board.
Director at Veeva (NYSE: VEEV) acquires stock via RSU vesting
Veeva Systems director Marshall Mohr acquired 288 shares of Class A Common Stock on March 1, 2026, through the exercise of Restricted Stock Units (RSUs) at a price of $0.00 per unit. This transaction is a result of a prior equity award granted on June 18, 2025, which vests quarterly for continued board service. Following the vesting, Mohr now directly holds 5,687 Class A shares and 289 RSUs, with the transaction noted as exempt from Section 16(b).
Veeva Systems (NYSE:VEEV) Sparks Elevated Positioning Chatter In Russell 1000 ETF Today
Veeva Systems (NYSE:VEEV), a company specializing in cloud software for life sciences organizations, is reportedly generating increased attention within the Russell 1000 ETF today. The article highlights Veeva's role in providing specialized platforms for pharmaceutical, biotechnology, and medical device companies. To access the full article, readers are prompted to log in or create an account, suggesting a premium content model.
More Than 125 Customers Worldwide Live on Vault CRM as Veeva Accelerates the Industry's Agentic Transformation
Veeva Systems announced that over 125 customers globally are now live on Veeva Vault CRM, its next-generation CRM for life sciences. This achievement, combined with the availability of Veeva AI, positions Vault CRM as a leader in agentic CRM and accelerates the industry's transformation. The customer base includes top biopharmas and companies across major regions.
More Than 125 Customers Worldwide Live on Vault CRM as Veeva Accelerates the Industry's Agentic Transformation
Veeva Systems announced that over 125 customers globally are now using Veeva Vault CRM, signifying the company's acceleration of agentic CRM in the life sciences industry. The success of Vault CRM, combined with Veeva AI, supports commercial and medical teams across the entire product lifecycle. Veeva has also updated the end-of-support date for Veeva CRM to December 2029 due to the robust adoption of Vault CRM.
Here's Why Artisan Mid Cap Fund Sold Its Position in Veeva Systems (VEEV)
Artisan Mid Cap Fund sold its position in Veeva Systems (VEEV) during Q4 2025, identifying it as a detractor despite solid recurring revenue growth. The decision was driven by rising competitive and AI-driven risks in the life sciences technology sector. The fund believes other AI stocks offer greater upside potential and less downside risk.
Veeva Systems (NYSE:VEEV) Emerges as a Prime GARP Stock Candidate
Veeva Systems (NYSE:VEEV) is highlighted as an ideal "Growth at a Reasonable Price" (GARP) stock, combining strong historic and forecasted growth with a fair valuation relative to its industry and the broader market. The company demonstrates outstanding profitability with high margins and exceptional financial health, characterized by zero debt and high liquidity. These factors position Veeva as a stable investment choice capable of navigating various market conditions.
Veeva QMS BioDlink Win Highlights Valuation Gap In Veeva Systems
Veeva Systems (NYSE:VEEV) recently announced that BioDlink successfully implemented Veeva QMS, a cloud-based quality management platform, highlighting Veeva's role in digital quality for life sciences. Despite this client win, Veeva's stock has seen a significant decline, trading about 43% below analyst targets and 32.1% below Simply Wall St's fair value estimate. This performance suggests a valuation gap, with the stock's recent weakness disconnecting from its fundamental role in the regulated biopharmaceutical sector.
Veeva Systems stock hits 52-week low at $177.82
Veeva Systems (NYSE: VEEV) stock has hit a new 52-week low of $177.82, reflecting a 23.6% decline over the past year and a 32.5% drop in the last six months, with its RSI in oversold territory. Despite the downturn, the company maintains strong financial health, holding more cash than debt, and its stock is trading below its Fair Value according to InvestingPro. Recent developments include a $2 billion share buyback program and mixed analyst ratings, with some downgrading due to maturing products and others upgrading, citing compelling valuation and strong customer migration to Veeva Vault CRM.
